Perspectives About Online Information
2 other identifiers
interventional
3,200
1 country
1
Brief Summary
The purpose of this research study is to understand the perspectives of U.S. adults on online information about prostate cancer. Study participants will receive different online information about prostate cancer to view such as a video post or text post, and complete a one-time online survey that will take approximately 10 minutes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable prostate-cancer
Started Jul 2026
Shorter than P25 for not_applicable prostate-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 2, 2026
CompletedFirst Posted
Study publicly available on registry
June 8, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2028
Study Completion
Last participant's last visit for all outcomes
January 31, 2028
June 8, 2026
June 1, 2026
1.6 years
June 2, 2026
June 2, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Trust in the post, as measured by a 4-point Likert scale
A single question is asked of "How much do you trust the information in the post?" Participants used a 4-point Likert scale from 1 (trust the information completely) to 4 (Did not trust the information). Scores range from 1-4, with higher scores indicating less trust.
Post-intervention (~5 minutes)
Secondary Outcomes (2)
Short-form Positive and Negative Affect Schedule (PANAS) Positive Score
Post-intervention (~5 minutes)
Short-form Positive and Negative Affect Schedule (PANAS) Negative Score
Post-intervention (~5 minutes)
Study Arms (2)
Prostate Cancer Post with Video
EXPERIMENTALParticipants will receive a survey and be asked their perspective after reviewing a prostate cancer post with video
Prostate Cancer Post without Video
EXPERIMENTALParticipants will receive a survey and be asked their perspective after reviewing a prostate cancer post without video.
Interventions
Participants will review a post about prostate cancer.
Participants will review a post about prostate cancer.
The survey will include questions about demographics and internet use. It may also provide participants with resources about online information.
Eligibility Criteria
You may qualify if:
- U.S. adult age 40+ who identifies as Black and/or Hispanic
- Enrolled in Dynata online survey panel
- Willing and able to participate in the research study.
You may not qualify if:
- Individuals up to age 39
- Individuals living outside the U.S.
- Individuals who are not Black and/or Hispanic
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NYU Langone Healthlead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
NYU Langone Health
New York, New York, 10016, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stacy Loeb, MD, MSc, PhD
NYU Langone Health
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 2, 2026
First Posted
June 8, 2026
Study Start (Estimated)
July 1, 2026
Primary Completion (Estimated)
January 31, 2028
Study Completion (Estimated)
January 31, 2028
Last Updated
June 8, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
- Access Criteria
- The investigator who proposed to use the data after signing a data use agreement will be granted access upon reasonable request for biomedical research purposes. Requests should be directed to stacy.loeb@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.
The de-identified participant data from the final research dataset will be shared upon reasonable request beginning 9 to 36 months after publication or as required by a condition of awards or supporting agreements, provided the requesting investigator executes a data use agreement with NYU Langone Health. This instance of data sharing will also require separate IRB review as well as review from NYU Langone's Data Sharing Strategy Board (DSSB). Requests should be directed to: stacy.loeb@nyulangone.org. The protocol and statistical analysis plan will be posted on Clinicaltrials.gov only as required by federal regulation or supporting awards and agreements.